Aminoglutethimide
Back to searchMolecule Structure
Scientific Name
Aminoglutethimide
Description of the Drug
Aminoglutethimide is an adrenocortical steroid synthesis inhibitor used in the treatment of Cushing’s syndrome.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00357
http://www.drugbank.ca/drugs/DB00357
Brand Name(s)
Cytadren, Orimeten
Company Owner(s)
Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cytochrome P450 19A1 | SINGLE PROTEIN | INHIBITOR | CHEMBL1978 |
Cytochrome P450 11A1 | SINGLE PROTEIN | INHIBITOR | CHEMBL2033 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4306 | |
PharmGKB | PA448375 | |
Human Metabolome Database | HMDB0014501 | |
DrugBank | DB00357 | |
PubChem: Thomson Pharma | 15068844 | |
PubChem | 2145 | |
Mcule | MCULE-9118268281 | |
NMRShiftDB | 60062198 | |
LINCS | LSM-1409 | |
Nikkaji | J5.378C | |
BindingDB | 9460 | |
EPA CompTox Dashboard | DTXSID8022589 | |
DrugCentral | 164 | |
Brenda | 15629 | 124968 |
ChemicalBook | CB5131691 | |
Guide to Pharmacology | 7054 | |
rxnorm | AMINOGLUTETHIMIDE | |
PubChem: Drugs of the Future | 12012594 | |
KEGG Ligand | C07617 | |
ChEBI | 2654 |